Latest triamcinolone acetonide Stories
MAPLE GROVE, Minn., July 11, 2011 /PRNewswire/ -- Today Upsher-Smith Laboratories, Inc. announced the launch of Trianex(TM) 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.
ALLEGAN, Mich., June 15, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) (previously Barr Laboratories Inc.) has begun shipping Triamcinolone Acetonide Nasal Spray.
EAST HANOVER, N.J., May 25, 2011 /PRNewswire/ -- Novartis announced today results of two pivotal Phase III trials in patients with severe gouty arthritis, showing that ACZ885 (canakinumab) provided superior pain relief and reduced the risk of suffering new attacks by up to 68% compared to an injectable steroid (triamcinolone acetonide, TA) used to treat gouty arthritis attacks(1,2).
Researchers led by specialists at the Johns Hopkins Wilmer Eye Institute have found that injecting a corticosteroid, triamcinolone, directly into the eye may slow the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.
Thai researchers suggest patients on allergy medicine are better served when they adjust their dose to symptoms.
BRIDGEWATER, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the U.S.
SurModics has announced that Merck & Co has decided to suspend enrollment of new patients in the Phase IIb study that is intended to evaluate the safety and efficacy of SurModics's I-vation triamcinolone acetonide in patients with diabetic macular edema.
- A volcanic mudflow.